Literature DB >> 17169815

CHEK2*1100delC and risk of chronic lymphocytic leukemia.

Gabrielle S Sellick, Kate Sullivan, Daniel Catovsky, Richard S Houlston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17169815     DOI： 10.1080/10428190600942462

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

1.  A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutations.

Authors:  Hanna Janiszewska; Aneta Bak; Maria Pilarska; Marta Heise; Anna Junkiert-Czarnecka; Małgorzata Kuliszkiewicz-Janus; Małgorzata Całbecka; Bozena Jaźwiec; Dariusz Wołowiec; Kazimierz Kuliczkowski; Olga Haus
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

Review 2.  Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.

Authors:  Ryan J Stubbins; Sophia Korotev; Lucy A Godley
Journal:  Curr Hematol Malig Rep       Date:  2022-06-08       Impact factor: 4.213

Review 3.  CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.

Authors:  Victoria Hale; Maren Weischer; Jong Y Park
Journal:  Prostate Cancer       Date:  2014-11-06

4.  Genetic associations of protein-coding variants in human disease.

Authors:  Benjamin B Sun; Mitja I Kurki; Christopher N Foley; Asma Mechakra; Chia-Yen Chen; Eric Marshall; Jemma B Wilk; Mohamed Chahine; Philippe Chevalier; Georges Christé; Aarno Palotie; Mark J Daly; Heiko Runz
Journal:  Nature       Date:  2022-02-23       Impact factor: 69.504
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.